List of Kaleido Biosciences patents | 5 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10314853 Glycan therapeutics and related methods thereof	Patent 10314853 was granted and assigned to Kaleido Biosciences on June, 2019 by the United States Patent and Trademark Office.		Kaleido Biosciences	United States Patent and Trademark Office	10314853	June 11, 2019
‌ US Patent 11229660 Glycan therapeutics and method of treating conditions associated with TMAO	Patent 11229660 was granted and assigned to Kaleido Biosciences on January, 2022 by the United States Patent and Trademark Office.	Kaleido Biosciences	Kaleido Biosciences	United States Patent and Trademark Office	11229660	January 25, 2022
‌ US Patent 10881676 Glycan therapeutics and related methods thereof	Patent 10881676 was granted and assigned to Kaleido Biosciences on January, 2021 by the United States Patent and Trademark Office.	Kaleido Biosciences	Kaleido Biosciences	United States Patent and Trademark Office	10881676	January 5, 2021
‌ US Patent 10894057 Glycan therapeutic compositions and related methods thereof	Patent 10894057 was granted and assigned to Kaleido Biosciences on January, 2021 by the United States Patent and Trademark Office.		Kaleido Biosciences	United States Patent and Trademark Office	10894057	January 19, 2021
‌ US Patent 10702542 Glycan therapeutics and related methods thereof	Patent 10702542 was granted and assigned to Kaleido Biosciences on July, 2020 by the United States Patent and Trademark Office.	Kaleido Biosciences	Kaleido Biosciences	United States Patent and Trademark Office	10702542	July 7, 2020